These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20709204)

  • 1. Cancer prevention I: introduction.
    Dunn BK; Greenwald P
    Semin Oncol; 2010 Jun; 37(3):190-201. PubMed ID: 20709204
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer prevention research: back to the future.
    Lippman SM
    Cancer Prev Res (Phila); 2009 Jun; 2(6):503-13. PubMed ID: 19491288
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemoprevention--history and general principles.
    Wu X; Patterson S; Hawk E
    Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):445-59. PubMed ID: 22122762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview: the late Larry C. Clark showed the bright side of the moon element (selenium) in a clinical cancer prevention trial.
    el-Bayoumy K
    Nutr Cancer; 2001; 40(1):4-5. PubMed ID: 11799921
    [No Abstract]   [Full Text] [Related]  

  • 5. [N. N. Petrov Research Institute of Oncology: present and future].
    Beliaev AM
    Vopr Onkol; 2012; 58(2):140-7. PubMed ID: 22774516
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chemoprevention of cancer. Prevention of cancer in groups with increased risk].
    Sanner T; Dybing E
    Tidsskr Nor Laegeforen; 1996 Aug; 116(19):2329-33. PubMed ID: 8804210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.
    Greenwald P
    J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sixty years of CA: a cancer journal for clinicians.
    Gansler T; Ganz PA; Grant M; Greene FL; Johnstone P; Mahoney M; Newman LA; Oh WK; Thomas CR; Thun MJ; Vickers AJ; Wender RC; Brawley OW
    CA Cancer J Clin; 2010; 60(6):345-50. PubMed ID: 21075954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of human trial findings.
    Huttunen JK
    IARC Sci Publ; 1996; (139):271-6. PubMed ID: 8923037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethical issues of intervention trials in cancer.
    Sancho-Garnier H; Joseph R
    IARC Sci Publ; 1996; (136):121-2. PubMed ID: 8791122
    [No Abstract]   [Full Text] [Related]  

  • 11. Methodological issues in the design of primary prevention trials.
    Gaziano JM; Hennekens CH; Buring JE
    IARC Sci Publ; 1996; (136):7-12. PubMed ID: 8791110
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of chemoprevention in cancer control.
    Greenwald P; Kelloff GJ
    IARC Sci Publ; 1996; (139):13-22. PubMed ID: 8923016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trials.
    Kelloff GJ; Boone CW; Steele VE; Crowell JA; Lubet R; Sigman CC
    Cancer Res; 1994 Apr; 54(7 Suppl):2015s-2024s. PubMed ID: 8137331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoprevention clinical trials: it is time to turn success into progress.
    Brown PH
    Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1531-2. PubMed ID: 17684123
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chemoprevention of cancers].
    Espie M
    Bull Cancer; 1995 Jul; 82 Suppl 3():181s-185s. PubMed ID: 7492832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of human trial design.
    Buiatti E
    IARC Sci Publ; 1996; (139):261-9. PubMed ID: 8923036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evidence-based approach to cancer prevention clinical trials.
    Greenwald P; McDonald SS; Anderson DE
    Eur J Cancer Prev; 2002 Aug; 11 Suppl 2():S43-7. PubMed ID: 12570334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer prevention: from 1727 to milestones of the past 100 years.
    Lippman SM; Hawk ET
    Cancer Res; 2009 Jul; 69(13):5269-84. PubMed ID: 19491253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk biomarkers and current strategies for cancer chemoprevention.
    Kelloff GJ; Boone CW; Crowell JA; Nayfield SG; Hawk E; Malone WF; Steele VE; Lubet RA; Sigman CC
    J Cell Biochem Suppl; 1996; 25():1-14. PubMed ID: 9027592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The critical role of risk-benefit assessments in cancer prevention.
    Hawk E; Viner JL
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):297-8. PubMed ID: 15734949
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.